Emphysema Completed Phase 2 Trials for Alpha-1-proteinase inhibitor (DB00058)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01213043Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin DeficiencyTreatment